393 related articles for article (PubMed ID: 12216107)
21. Prediction of pathology and survival by FDG PET in gliomas.
Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
[TBL] [Abstract][Full Text] [Related]
22. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
[TBL] [Abstract][Full Text] [Related]
23. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
Pirotte B; Goldman S; Dewitte O; Massager N; Wikler D; Lefranc F; Ben Taib NO; Rorive S; David P; Brotchi J; Levivier M
J Neurosurg; 2006 Feb; 104(2):238-53. PubMed ID: 16509498
[TBL] [Abstract][Full Text] [Related]
24. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.
Prieto E; Martí-Climent JM; Domínguez-Prado I; Garrastachu P; Díez-Valle R; Tejada S; Aristu JJ; Peñuelas I; Arbizu J
J Nucl Med; 2011 Jun; 52(6):865-72. PubMed ID: 21571807
[TBL] [Abstract][Full Text] [Related]
25. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
[TBL] [Abstract][Full Text] [Related]
26. PET scanning and the human immunodeficiency virus-positive patient.
O'Doherty MJ; Barrington SF; Campbell M; Lowe J; Bradbeer CS
J Nucl Med; 1997 Oct; 38(10):1575-83. PubMed ID: 9379195
[TBL] [Abstract][Full Text] [Related]
27. Correlation of
Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
[TBL] [Abstract][Full Text] [Related]
28. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Bénard F; Romsa J; Hustinx R
Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
[TBL] [Abstract][Full Text] [Related]
29. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
[TBL] [Abstract][Full Text] [Related]
30. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
Kim S; Chung JK; Im SH; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):52-9. PubMed ID: 15309332
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
[TBL] [Abstract][Full Text] [Related]
32. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET.
Sasaki M; Kuwabara Y; Ichiya Y; Akashi Y; Yoshida T; Nakagawa M; Murayama S; Masuda K
J Nucl Med; 1999 Oct; 40(10):1595-601. PubMed ID: 10520697
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
[TBL] [Abstract][Full Text] [Related]
34. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
[TBL] [Abstract][Full Text] [Related]
35. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.
Yamada Y; Uchida Y; Tatsumi K; Yamaguchi T; Kimura H; Kitahara H; Kuriyama T
J Nucl Med; 1998 Jul; 39(7):1160-6. PubMed ID: 9669387
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with.
Tsuyuguchi N; Matsuoka Y; Sunada I; Matsusaka Y; Haque M
AJNR Am J Neuroradiol; 2001 Feb; 22(2):311-3. PubMed ID: 11156775
[TBL] [Abstract][Full Text] [Related]
37. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.
Ogawa T; Inugami A; Hatazawa J; Kanno I; Murakami M; Yasui N; Mineura K; Uemura K
AJNR Am J Neuroradiol; 1996 Feb; 17(2):345-53. PubMed ID: 8938309
[TBL] [Abstract][Full Text] [Related]
38. [The PET scan in neuro-oncology--indications, differential diagnosis and clinical application].
Novák L; Emri M; Balkay L; Galuska L; Esik O; Molnár P; Csécsei G; Trón L
Orv Hetil; 2002 May; 143(21 Suppl 3):1289-94. PubMed ID: 12077919
[TBL] [Abstract][Full Text] [Related]
39. Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions.
Pirotte BJ; Lubansu A; Massager N; Wikler D; Van Bogaert P; Levivier M; Brotchi J; Goldman S
J Neurosurg Pediatr; 2010 May; 5(5):479-85. PubMed ID: 20433262
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography imaging of brain tumors.
Wong TZ; van der Westhuizen GJ; Coleman RE
Neuroimaging Clin N Am; 2002 Nov; 12(4):615-26. PubMed ID: 12687915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]